Navigation Links
University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
Date:7/7/2008

WHITE PLAINS, N.Y., July 7 /PRNewswire/ -- The Leukemia & Lymphoma Society has awarded a $550,000 grant to Jonathan Friedberg M.D., M.M.Sc., of the James P. Wilmot Cancer Center at the University of Rochester Medical Center. Millennium Pharmaceuticals, The Takeda Oncology Company, of Cambridge, Mass., is funding the first two years of the five-year program.

The Scholar in Clinical Research Career Development Grant will support Dr. Friedberg's work on a new targeted treatment for lymphoma patients.

Dr. Friedberg is studying the drug R788 for patients with indolent and mantle cell non-Hodgkin lymphoma (NHL). This drug inhibits the molecule called SYK, which controls the survival of B-cells in lymphoma patients. Dr. Friedberg has already shown in several patients that R788 is safe and effective. He is now using mouse models to evaluate R788 in combination with other agents to kill lymphoma cells even better. Once the most promising combination is identified, Dr. Friedberg will pursue a clinical trial enrolling patients with relapsed indolent and mantle cell NHL.

"To effectively eradicate cancers we must learn which molecules cause them and then develop new treatments that kill cancer cells without harming healthy cells," said Barton Kamen, M.D., PhD, Chief Medical Officer of LLS. "Dr. Friedberg's work shows exceptional promise and is likely to lead to improved treatments for patients with various types of lymphoma."

Friedberg is Associate Professor of Medicine, and Director of Hematological Malignancies Clinical Research at the Wilmot Cancer Center. He is leading a number of clinical studies of new agents for lymphoma patients.

The LLS Career Development Program funds talented investigators at different points in their developing careers: Fellows and Special Fellows during their post-doctoral training years, and Scholars and Scholars in Clinical Research early in their independent academic positions. The program thereby recruit
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
2. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
3. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
4. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
5. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
6. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
7. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
8. BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
9. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
10. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
11. Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... has announced the addition of the ... to their offering.      (Logo: ... been broadly classified into wide categories based ... for the treatment of different gynecological conditions ...
(Date:9/19/2014)... 2014  4WEB Medical announces the formal launch of ... osteotomy implants on the market today at this ... in Chicago .  The Osteotomy Truss ... needs with 74 size options included in one versatile ... only 15 to 18 implant sizes, which limited a ...
(Date:9/19/2014)... 2014 UBM Medica US announces that  ... to help oncologists and other clinicians gain a better ... of targeted therapies and immunotherapies, discusses some of the ... Every September, Blood Cancer Awareness Month ... about blood cancers—helping to increase survival rates and improve ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 34WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4
... Cellceutix Corporation (Pink Sheets: CTIX ) today ... Agreement (CDA) pertaining to its anti-cancer drug, Kevetrin™, with ... Cellceutix CEO, Leo Ehrlich, commented, "It,s relatively uncommon ... a compound before clinical trials are underway.  The process ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ... Paul Bisaro, Watson,s President and Chief Executive Officer, will ... at the Barclay,s 2011 Global Healthcare Conference ... presentation will be webcast live and can be accessed ...
Cached Medicine Technology:Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company 2Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company 3
(Date:9/20/2014)... York, New York (PRWEB) September 20, 2014 ... power morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological ... that yet another insurer has announced plans to ... statement posted on its website last month, Harrisburg, ... procedures effective November 1, 2014. The insurer said ...
(Date:9/20/2014)... 2014 Recently, Best Cheap Hosting ... launched its new website. The new site provides ... hosting products for customers. Here, people can find ... purchasing decision. Also, it has recommended some excellent ... One of the great web hosting suppliers, InMotion ...
(Date:9/20/2014)... Traditionally dentists have advised their patients against drinking coffee ... is re-visiting that advice and changing his stance after considering ... have on oral health. “There’s good news and great news,” ... beneficial in protecting against gum disease, and red wine can ... was from the September 2014 issue of Boston University ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Recently, UWDress.com, ... dresses and women’s special occasion outfits, has launched a ... The company’s prom outfits are popular among worldwide clients. ... get wholesale prom dresses on its website. ... for customers from around the world. Great custom made ...
(Date:9/20/2014)... New York, NY (PRWEB) September 20, 2014 ... million of their customers may have had their credit card ... late last year, spawning a slew of headline articles ... but those weren’t the only eye opening numbers. , ... numbers were stolen, almost like it’s a way to score ...
Breaking Medicine News(10 mins):Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5
... Healthcare Leaders With Information and,Best Practices Related ... WASHINGTON, April 17 The new ... that will eliminate or,reduce payments for three ... a two-day conference for healthcare executives and ...
... Projects show potential of computer science to profoundly impact prediction ... and treatment ... with the ability to predict and prevent adverse drug responses,within ... illnesses such as Parkinson,s disease and Alzheimer,s,disease, are just two ...
... In a move that will benefit children of ... premier childrens hospitals in the United States, and the ... have formalized a longtime relationship by officially becoming international ... sister cities, the formal linkage of hospitals in two ...
... Trust Inc.,(NYSE: CRE ) today announced it named ... Care,s Board of Directors, which increases the,number of members ... as President of Corporate Finance at CIT, Owens, 48, ... leaders,in assessing their go-to-market models, developing integrated distribution,platforms that ...
... 2008 Babies with an eye-alignment disorder called ... but development catches up after corrective surgery, reports ... (American Association for Pediatric Ophthalmology and Strabismus). , ... Retina Foundation of Southwest Texas, Dallas, the researchers ...
... Technology through ... ... Medical,Solutions USA Inc. (http://www.siemens.com/healthcare ) today announced a ... in numerous,strategic healthcare industry organizations., (Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ...
Cached Medicine News:Health News:APIC Conference to Address New CMS Regulations 2Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 2Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 3Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 4Health News:Scientists Explore Human Gene Pool With Help From Microsoft Research 5Health News:Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals 2Health News:Care Investment Trust Names Walter J. Owens to Board of Directors 2Health News:Infantile esotropia linked to developmental delays 2Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 2Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 3Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 4Health News:Siemens Healthcare Executives Recognized With New Industry Leadership Positions 5
ELISA kit for Varicella-zoster IgM....
... (VZV) IgG Enzyme-Linked Immunosorbent Assay (ELISA) is ... of IgG antibody to VZV in human ... used for the determination of immune status. ... used to demonstrate seroconversion or a significant ...
... The Zeus Scientific, Inc. Mumps IgG ELISA ... detection of Mumps IgG antibody in human ... the results of this test, together with ... determination of immune status, and/or aid in ...
... The Trinity Biotech Mumps IgM ... intended for the qualitative detection ... serum to Mumps for the ... performance characteristics of this kit ...
Medicine Products: